<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dialogues Clin Neurosci</journal-id><journal-id journal-id-type="pmc">Dialogues Clin Neurosci</journal-id><journal-title-group><journal-title>Dialogues in Clinical Neuroscience</journal-title></journal-title-group><issn pub-type="ppub">1294-8322</issn><issn pub-type="epub">1958-5969</issn><publisher><publisher-name>Les Laboratoires Servier</publisher-name><publisher-loc>France</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22033546</article-id><article-id pub-id-type="pmc">3181572</article-id><article-categories><subj-group subj-group-type="heading"><subject>State of the Art</subject></subj-group></article-categories><title-group><article-title>Depression in late life</article-title><trans-title-group xml:lang="es"><trans-title>Depresion en sujetos de edad avanzada</trans-title></trans-title-group><trans-title-group xml:lang="fr"><trans-title>La d&#x000e9;pression du sujet &#x000e2;g&#x000e9;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Barry</surname><given-names>D. Lebowitz</given-names></name><degrees>PhD</degrees><xref ref-type="corresp" rid="COR1">*</xref><aff>Adult and Geriatric Treatment and Preventive Interventions Research Branch, National Institute of Mental Health, Bethesda, Md, USA</aff></contrib></contrib-group><author-notes><corresp id="COR1"><label>*</label>
E-mail: <email>e-mail: blebowit@mail.nih.gov</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>1999</year></pub-date><volume>1</volume><issue>2</issue><fpage>57</fpage><lpage>65</lpage><permissions><copyright-statement>Copyright: &#x000a9; 1999 LLS</copyright-statement><copyright-year>1999</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Despite its prevalence and seriousness, depression in late life remains underappreciated as a source of disability and suffering for older people and their families. Despite a solid and substantial body of research, recognition of depression remains problematic and is often attributed to normal developmental changes in aging. Treatment efficacy data notwithstanding, the adequacy and appropriateness of treatment is highly variable. This paper contains a broad overview of new research developments in depression in late life and the disabilities associated with it Serving as an introduction to the specific papers that follow in this issue of <italic>Dialogues in Clinical Neuroscience,</italic> this article scans the knowledge base in basic, clinical, and health services research, identifying the highlights of current work in the area and proposing areas of needed expansion of research efforts.</p></abstract><trans-abstract xml:lang="es"><p>A pesar de su alta prevalencia y de su gravedad, la depresi&#x000f3;n en los estadios avanzados de la vida contin&#x000fa;a siendo menospreciada. Ella causa incapacidad sufrimiento en los sujetos de edad avanzada y en su entorno familiar. Aunque hay s&#x000f3;lidos y sustanciales datos que provienen de la investigati&#x000f3;n, el reconocimiento de la depresi&#x000f3;n contin&#x000fa;a siendo un problema y se la considera todav&#x000ed;a como una adaptaci&#x000f3;n normal al envejecimiento. Aunque existen datos sobre la eficacia de su tratamiento, la adecuaci&#x000f3;n y especificidad de &#x000e9;ste es altamente variable. Este art&#x000ed;culo entrega una visi&#x000f3;n general de los &#x000fa;ltimos desarrollos de la investigati&#x000f3;n en el campo de la depresi&#x000f3;n en estadios avanzados de la vida y de las incapacidades que ella conlleva. Este art&#x000ed;culo sirve de introducci&#x000f3;n a los termas espec&#x000ed;ficos de este n&#x000fa;mero de <italic>Dialogues in Clinical Neuroscience</italic> y revisa los aspectos m&#x000e1;s importantes de la investigati&#x000f3;n b&#x000e1;sica y cl&#x000ed;nica, como tambi&#x000e9;n la atenci&#x000f3;n que ofrecen los servicios de salud. Se identifican los aspectos m&#x000e1;s relevantes del trabajo actual en esta &#x000e1;rea y se proponen las v&#x000ed;as necesarias para extender los esfuerzos en futuras investigaciones.</p></trans-abstract><trans-abstract xml:lang="fr"><p>En d&#x000e9;pit de sa fr&#x000e9;quence et de sa gravit&#x000e9;, la d&#x000e9;pression du sujet &#x000e2;g&#x000e9; reste sous-estim&#x000e9;e en tant que source d'incapacit&#x000e9; et de souffrance, autant pour le sujet concern&#x000e9; que pour son entourage. Malgr&#x000e9; des donn&#x000e9;es solides et substantielles fournies par la recherche, la reconnaissance de la d&#x000e9;pression  demeure probl&#x000e9;matique, au point qu'elle est souvent attribu&#x000e9;e aux cons&#x000e9;quences physiologiques du vieillissement. Malgr&#x000e9; l'efficacit&#x000e9; d&#x000e9;montr&#x000e9;e du traitement, l'ad&#x000e9;quation et l'opportunit&#x000e9; de celui-ci sont des plus variables. Cet article donne une large vue d'ensemble sur les nouvelles voies de recherche qui gravitent autour de la d&#x000e9;pression du sujet &#x000e2;g&#x000e9;, mais aussi sur les handicaps qui lui sont associ&#x000e9;s. Il sert d'introduction aux articles plus sp&#x000e9;cifiques qui suivent dans ce num&#x000e9;ro de <italic>Dialogues in Clinical Neuroscience</italic>, en examinant les connaissances de base dans des domaines de recherche aussi divers que les sciences fondamentales, la clinique et les services de sant&#x000e9;. Il souligne aussi les ph&#x000e9;nom&#x000e8;nes les plus marquants dans les travaux en cours et propose des voies qui devraient b&#x000e9;n&#x000e9;ficier d'efforts de recherche soutenus.</p></trans-abstract><kwd-group><kwd><italic>epidemiology</italic></kwd><kwd><italic>pathophysiology</italic></kwd><kwd><italic>natural history</italic></kwd><kwd><italic>disability</italic></kwd><kwd><italic>pharmacology</italic></kwd><kwd><italic>psychotheapy</italic></kwd><kwd><italic>convulsive therapy</italic></kwd><kwd><italic>health services</italic></kwd><kwd><italic>suicide</italic></kwd></kwd-group></article-meta></front><body><p>Three factors combine to make depression in late life a primary concern in worldwide public health. First, the global population is growing older, gaining nearly 30 years of life expectancy in this century.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Second, our appreciation of the disabling consequences of depression has been underscored by the landmark report of the World Health Organization on the &#x0201c;global burden of disease.&#x0201d;<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Third, the tools of contemporary neuroscience have significantly enhanced our understanding of the pathophysiologic and etiologic mechanisms of depression.<sup><xref ref-type="bibr" rid="ref3">3</xref>-<xref ref-type="bibr" rid="ref7">7</xref></sup>
</p><p>Depression in older people is a significant public health problem.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> It is the cause of unnecessary suffering for those whose illness is unrecognized or inadequately treated, and it burdens families and institutions providing care for the elderly. Because of the stereotypic notion that older people are necessarily beset by many physical illnesses and social and economic problems, clinicians, family members, and older people themselves often conclude that depression is a normal condition of late life. Clinically, the symptom of depressed mood may be less commonly reported than a variety of somatic complaints, sleep and appetite change, and general loss of interest.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> These factors combine to make diagnosis and treatment of depression highly variable and problematic.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup>
</p><p> This paper, and the other papers in this issue, will demonstrate that depression in older people is widespread and serious, and that the comorbidity of depression with other illnesses is particularly significant. Moreover, we will show that depression can be diagnosed in the older patient and that it can be differentiated from normal aging. Importantly, a variety of treatments have been demonstrated to be safe and efficacious in the elderly, and long-term treatment might be indicated.</p><sec><title>Onset and course of depression</title><p>Depression in late life is a very heterogeneous condition. Onset may be early in life with the course recurrent from a first episode earlier in adulthood, or the onset of the first episode may be late in life. In general, compared with patients of the same age with recurrent depression, those patients with the first onset of depression in late life are likely to have a less satisfactory response to treatment and a more chronic course.</p><p>There are significant brain changes in depression: frontal and temporal lobe atrophy,<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> periventricular and subcortical deep white matter hyperintensities,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> and significantly decreased metabolism in a variety of brain regions (dorsolateral prefrontal cortex, inferior frontal cortex, basal ganglia).<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> Many of these changes are associated with normal aging as well. Late-onset depression often is associated with a variety of brain abnormalities, such as ventriculomegaly and white matter hyperintensities, and with cognitive impairments. Recent research has uncovered important sources of clinical and biological heterogeneity within late-life-onset depression, and subgroups with distinctive patterns of clinical presentations, course, mechanisms, and outcomes have been identified.<sup><xref ref-type="bibr" rid="ref15">15</xref>-<xref ref-type="bibr" rid="ref17">17</xref></sup>
</p><p>The association between depression and cognitive impairment has been well established, though the direction of causality has been disputed, as has the methodology of assessment.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> There does seem to be general agreement, however, that late-life depression with cognitive impairment that is reversed by antidepressant treatment is, more often than not, a predictor of the development of an irreversible dementia such as Alzheimer's disease or vascular dementia.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup>
</p><p>Converging findings implicate vascular disease in the pathogenesis of one particular subgroup. Geriatric depression is often comorbid with vascular disorders and is accompanied by lesions in the basal ganglia and prefrontal areas of the brain. The clinical profile of depression in patients with vascular disease is often characterized by motor retardation, lack of insight, and impairment of executive functions. This clinical presentation suggests that dysfunction of frontal brain systems is a possible contributing factor to depression in late life.<sup><xref ref-type="bibr" rid="ref21">21</xref>-<xref ref-type="bibr" rid="ref24">24</xref></sup> It also suggests that treatment for cerebrovascular disease may have preventive implications for latelife-onset depression. The article by Alexopoulos and colleagues in this issue of <italic>Dialogues in Clinical Neuroscience</italic> addresses this specific topic.</p></sec><sec><title>Comorbidity and disability</title><p>Depression coexisting with physical illness has been shown to increase levels of functional disability, increase the use of health care resources, reduce the effectiveness of rehabilitation in older patients with stroke, Parkinson's disease, heart disease, pulmonary disease, and fractures, and increase risk of death.<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref></sup> Depression has been shown to exert a strong and independent effect on functional disability. That effect is independent of diagnosis or overall medical burden. Functional disability itself predicts the development of depression and, conversely, depressive symptomatology is a risk factor for the onset or progression of disability.<sup><xref ref-type="bibr" rid="ref27">27</xref>-<xref ref-type="bibr" rid="ref30">30</xref></sup> Studies have shown that treatment for depression is safe and effective in patients with complex patterns of comorbidity, and suggest that treatment for depression can reduce excessive levels of disability and result in improved levels of functioning.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup>
</p><p>Studies of the psychosocial and medical correlates of late-life depression have also suggested possible mechanisms for the development of depression in older persons. There is substantial ongoing research on the central nervous system effects of the cytokines, particularly interleukin-1&#x003b2;, in Cortisol production, inflammation, and immune system activation. It is hypothesized that these mechanisms may be involved in the physiological and behavioral responses to illness and the genesis of depression.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> 'lite article by Katz in this issue of <italic>Dialogues in Clinical Neuroscience</italic> specifically examines this topic.</p></sec><sec><title>Subsyndromal depression in the elderly</title><p>Evidence is mounting to support the notion that clinically significant depression is a spectrum disorder rather than a categorical disease entity. While recent studies report a 1% to 2% prevalence of major depression and a 2% prevalence of dysthymia among community-dwelling elderly, much higher rates (13% to 27%) are observed in this age group for subsyndromal depressions.<sup><xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup> Subsyndromal depressions are levels of depressive symptoms (referred to as subsyndromal, subclinical, or symptomatic depression) that are associated with increased risk of major depression, physical disability, medical illness, and high use of health services but that do not meet the <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> 4 edition (DSM-TV) criteria for major depression or dysthymia.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> In medically ill elderly and nursing home residents, the prevalence of such symptom levels may be as high as 50%. <sup><xref ref-type="bibr" rid="ref35">35</xref></sup> The course of subsyndromal depressions is variable, but in the context of severe physical disability, from stroke, for example, the depressive symptomatology can be persistent over extended periods of time.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup> Ongoing research is actively pursuing questions of treatment response in subsyndromal depressions and whether interventions can have more generalized benefits on functional disability, quality of life, and needs for health care.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup>
</p></sec><sec><title>Gender and hormonal issues</title><p>One of the most striking and consistent findings in psychiatric epidemiology is that women have higher rates of all types of depression than men. Increases in depression have been observed among women during natural or surgical menopause and in response to antiestrogen therapy for breast cancer. Though still under debate, symptoms attributed to menopause-related changes in mid-life women include: depressed mood; decreased self-confidence; difficulty making decisions; anxiety; insomnia and fatigue; problems in memory and concentration; and decreased libido.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> Hormone replacement therapy has been associated with improvements in mood and quality of life, but the data are still very preliminary.</p><p>Despite claims in the popular media, there is no evidence supporting the antidepressant effects of the androgens testosterone and dehydroepiandosterone (DHEA) in either men or women.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> The data on hormonal factors in the development and treatment of depression remain preliminary, with some suggestive leads for further study.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> A more detailed understanding of these interactions,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> and prospective clinical trials, will be needed to determine whether manipulation of estrogen and other sex steroids has a significant role in the treatment of depression in late life.</p></sec><sec><title>Treatment issues</title><p>The goals of treatment are to achieve remission of symptoms, prevent relapse and recurrence, and improve the quality of life and functional capacity.</p><sec><title>Pharmacotherapy</title><p>In general, the older tricyclic antidepressants (TCAs) and the newer selective serotonin reuptake inhibitors (SSRIs) have comparable efficacy in elderly patients. The newer drugs of mixed action have not been extensively studied in the elderly. 'ITtic SSRIs are coming to be seen as preferable largely because of ease of use, less dosage adjustment, different side effect profiles including a reduced anticholinergic and cardiovascular burden, and greater acceptance.<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> The article by Schneider in this issue of <italic>Dialogues in Clinical Neuroscience</italic> specifically addresses this topic. It is uncertain whether this conclusion applies to clinically important subgroups such as those patients with chronic and very severe levels of major depression, or to very old patients.</p></sec><sec><title>Side effects</title><p>As in younger adults, the elderly tend to tolerate the SSRIs better than TCAs. This is based on fewer anticholinergic effects, little or no adverse effects on cognition at recommended doses, and minimal cardiovascular effects. Common complaints linked to SSRIs include nausea, diarrhea, insomnia, headache, agitation, and anxiety. Side effects of SSRIs that may be relatively more common or more problematic in older patients include SSRI-induced syndrome of inappropriate antidiuretic hormone secretion (STADH), extrapyramidal symptoms, and bradycardia.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Based on available data, it is not possible to determine whether the elderly are more sensitive to these more frequent side effects than younger populations. It should be noted that SSRIs are metabolized in the liver and inhibit the drug-metabolizing enzyme cytochrome P450, the route through which many other medications commonly taken by older people are metabolized. Such drugs include &#x003b2;-blockers, class Ic antiarrhythmics, and benzodiazepines. The combination of drugs may result in clinically significant alterations in drug concentration levels or in complex drug interactions:<sup><xref ref-type="bibr" rid="ref44">44</xref>-<xref ref-type="bibr" rid="ref46">46</xref></sup>
</p></sec><sec><title>Psychotherapy</title><p>Research has clearly demonstrated the efficacy of standardized approaches to treatment, such as cognitivebehavioral therapy, interpersonal therapy, and problem-solving therapy, both alone and in combination with pharmacotherapy.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> No single standardized approach to psychosocial treatment has a consistent advantage.<sup><xref ref-type="bibr" rid="ref48">48</xref>-<xref ref-type="bibr" rid="ref50">50</xref></sup> Psychotherapy is a powerful component of long-term treatment strategies where the contribution of therapy alone has been shown to provide substantial benefit in prolonging periods of good health free from depression.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> Psychotherapy also has particular utility in older patients who cannot or will not tolerate medication, or who are dealing with obviously stressful situations, interpersonal difficulties, or low degrees of social support.</p></sec><sec><title>Electroconvulsive therapy</title><p>Electroconvulsive therapy (ECT) remains an important, safe, and efficacious approach to the acute treatment of depression in older patients.<sup><xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref52">52</xref></sup> ECT is particularly useful in older patients whose medical condition is so fragile that they cannot tolerate pharmacotherapy, or in patients who are so acutely suicidal that a rapid response is required. ECT is also commonly used with patients who have not responded to pharmacotherapy and for patients with psychotic depression. Relapse rates following ECT are very high, however.<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> Important research is now investigating the longer-term efficacy of continuation pharmacotherapy and continuation ECT to address the problem of relapse.</p></sec><sec><title>Long-term treatment</title><p>Evidence has also continued to accumulate on the necessity for long-term treatment in late-life depression. Indeed, older patients with recurrent depression may need antidepressant treatment indefinitely to remain well. Moreover, long-term treatment should be of the same type and same intensity as that which was successful in the initial, acute phase. This is in contrast to much prevailing practice; longitudinal data demonstrate that the intensity of antidepressant treatment typically decreases prematurely, prior to 8 weeks of recovery.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> The appropriate intensity for maintenance regimens using psychotherapy only has not been systematically studied. Treatment response and long-term outcome for older patients are generally similar to those observed in mid-life adults, but the temporal course may be somewhat slower in the elderly and the risk of relapse somewhat greater.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> These differences are especially pronounced in patients over the age of 70.<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> The article by Schneider in this issue of <italic>Dialogues in Clinical Neuroscience</italic> is devoted to issues in treatment.</p></sec></sec><sec><title>Health care service and resource use</title><p>In mixed age samples, major depression leads to excessive utilization of medical services and greater health care costs. In nursing homes and among high utilizers of medical services, patients with depression incur significant increases in direct costs for medical care.<sup><xref ref-type="bibr" rid="ref57">57</xref>-<xref ref-type="bibr" rid="ref60">60</xref></sup>
</p><p>Longitudinal data demonstrate that depressive symptomatology in elderly primary care patients is associated with increased physician visits, medication use, emergency room visits, and outpatient charges.<sup><xref ref-type="bibr" rid="ref61">61</xref>,<xref ref-type="bibr" rid="ref62">62</xref></sup> Among medical inpatients, major depression has been associated with increased utilization of health care resources, including longer hospital stays and greater mortality, for example, in those undergoing elective coronary artery bypass grafting.<sup><xref ref-type="bibr" rid="ref63">63</xref>-<xref ref-type="bibr" rid="ref65">65</xref></sup> After discharge, depression accounts for a substantial increase in ambulatory health care use.<sup><xref ref-type="bibr" rid="ref66">66</xref></sup>
</p><p>The general health care sector is by far the principal source of treatment for older persons with depression. Recently analyzed data from the 1987 National Medical Expenditure Survey show that over 55% of older persons using mental health care received this care from general physicians. In contrast, less than 3% of individuals over age 65 report having received outpatient treatment from mental health professionals, a proportion lower than that for any other adult age group.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup>
</p><p>The scope and responsibility of primary care providers are being expanded and redefined in many health care systems. Primary care providers are charged with greater responsibility for diagnosis, treatment, and longterm management in all areas of health care, including care of older patients with mental disorders. That being the case, older people may derive substantial benefit from increased sensitivity to identification of depression on the part of their primary care physicians. Interventions directed toward improvement, recognition, and treatment, however, have not necessarily translated into added benefit when compared to practice as usual in the primary care setting.<sup><xref ref-type="bibr" rid="ref68">68</xref>-<xref ref-type="bibr" rid="ref70">70</xref></sup>
</p></sec><sec><title>Suicide and late-life depression</title><p>Suicide rates increase with age in most countries of the world, and men outnumber women suicide completers by a substantial amount. Recent studies of completed suicide have reinforced the close association with major depressive illness, especially in the elderly.<sup><xref ref-type="bibr" rid="ref71">71</xref>,<xref ref-type="bibr" rid="ref72">72</xref></sup> With increased age, the relative importance of the contribution of depression to suicide risk is magnified. The typical clinical profile of the older suicide completer is lateonset, nonpsychotic, unipolar depression of moderate severity uncomplicated by substance abuse or personality disorder.</p><p>Tragically, the depression in these older people was rarely recognized or treated. The failure to recognize and treat depression was not due to restricted access to care. A majority of these depressed suicide victims had seen a health care provider in the last month of life, 39% in the last week, and 20% on the day of suicide.<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> 'ITtie article by Bruce and Pearson in this issue of <italic>Dialogues in Clinical Neuroscience</italic> examines this topic.</p></sec><sec><title>Future directions</title><sec><title>Practice-relevant intervention studies</title><p>The rich and valuable literature on treatment of depression in late life has not been as informative for practice as it might be. In particular, we do not know why treatments rarely work as well in practice as they do in clinical trials, whether treatment enhances functioning, whether early treatment predicts a more favorable response, how can we keep people well once they have been made well, or the approaches that should be used for the treatment-resistant patient.</p><p>These issues are raised within the context of what has been called a public health model of treatment.<sup><xref ref-type="bibr" rid="ref74">74</xref></sup> We cannot yet address these as well as we would like, however, largely because the direction and culture of treatment research has been determined by a more narrowly defined regulatory model<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> geared to the approval and registration of pharmacologic agents. This regulatory model has been the dominant force shaping treatment research.</p><p>In general, the rigid exclusions of most regulatory-oriented clinical trials have significantly distorted the conclusions of these studies. Age itself is the most common concern, with most studies being restricted, to all intents and purposes, to the &#x0201c;young-old&#x0201d; population of patients in their sixties. Few older patients have ever been studied<sup><xref ref-type="bibr" rid="ref76">76</xref></sup> despite the clear impact of advanced age on pharmacokinetics, dynamics, and drug metabolism<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> and on treatment response.<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> Geriatric treatment research protocols have simply taken mid-life adult protocols and substituted a different age-range while keeping the remainder of the study unchanged with respect to eligibility, dosing, duration of treatment, and instrumentation.</p><p>Studies that are informed by a public health model are often called &#x0201c;effectiveness studies.&#x0201d; Public health studies bring research into the world of actual practice with time -pressured clinicians taking care of large numbers of patients with uncertain clinical presentations, complex comorbidities, varying degrees of interference, and with ideal levels of compliance. The exclusive focus on symptomatology is expanded to include outcomes related to issues of function, disability, morbidity, mortality, resource use, and quality of life. The classic public health trial is used to assess the expected outcome under usual circumstances of practice.</p><p>In contrast to the elegantly crafted efficacy trial, a public health trial must be bigger in size, simpler in design, broader in terms of inclusions, and narrower in terms of exclusions, and more representative with respect to settings of care. These settings will not be limited to academic health centers or tertiary care institutions, but will include primary care, community settings, and long-term care institutions. Unlike efficacy trials where specially trained clinicians carry out state-of-the-art assessment and treatment, public health trials are carried out in settings of usual practice where there is a broad and variable range of clinician expertise and experience with the disorder under study. Outcome measures will necessarily extend beyond symptomatology to include function, disability, morbidity, mortality, health care and other resource use, family burden, institutionalization, and quality of life.</p></sec><sec><title>Development of preventive interventions</title><p>Given the breadth and depth of the knowledge base regarding depression in late life, a clear opportunity is now presented to mount an initiative directed toward prevention. Prevention has many aspects. An intervention may be based on models of pathophysiology or etiology to prevent onset of the illness. Vascular depression presents one such opportunity, as does the research on bereavement<sup><xref ref-type="bibr" rid="ref77">77</xref>-<xref ref-type="bibr" rid="ref79">79</xref></sup> and a variety of comorbidities, such as vision or hearing loss and other illnesses. In the context of treatment, preventive interventions may well be directed at relapse, recurrence, or excessive levels of functional disability.</p></sec><sec><title>Safety and consumer protection</title><p>As part of a public health mission, we must also attend to issues of safety and consumer protection. For example, the widespread use of over-the-counter, unregulated treatments needs to be carefully examined for possible benefit and for potential harm. Use of complementary and alternative approaches is very high and growing.<sup><xref ref-type="bibr" rid="ref80">80</xref>,<xref ref-type="bibr" rid="ref81">81</xref></sup> Even in patients volunteering for participation in clinical drug trials, use of herbal medications is substantial; in a series of 150 such subjects,<sup><xref ref-type="bibr" rid="ref82">82</xref></sup> 56% reported having used herbs in the last month. It is therefore incumbent upon us to evaluate these treatments including natural products such as St John's Wort or kava, psychophysiologic approaches such as eye movement desensitization reprocessing (EMDR), and somatic approaches such as acupuncture, if for no other reason than that our patients are using these in large, uncontrolled, natural experiments.</p></sec><sec><title>Dissemination</title><p>A final priority must be dissemination. Our patients are not helped by treatments that are available in only in scientific journals. A recent example highlights the problem. Lehman and Steinwachs<sup><xref ref-type="bibr" rid="ref83">83</xref></sup> report that fewer than half the patients with schizophrenia in the United States received a level of care that was consistent with the current state of the art. This is an important finding that cannot be ignored. As a field we must take on the challenge of translating our research into practice and placing the most powerful clinical tools in the hands of patients, their families, and the clinicians that take care of them. The Geriatric Psychiatry Alliance initiatives on depression<sup><xref ref-type="bibr" rid="ref84">84</xref></sup> represent an important and potentially valuable approach to this problem.</p></sec></sec><sec><title>Conclusions</title><p>There has been significant progress in our understanding of the nature, clinical course, and treatment of depression in late life. Important findings have emerged in a number of areas directly affecting clinical care and have, in turn, stimulated further research. These findings include: the association of late-onset depression with brain abnormalities and vascular disease; the mutual reinforcement of depression and functional disability; the clinical importance of subsyndromal states; the possible role of sex steroids; the clinical utility of new antidepressant treatments, including the SSRIs and standardized psychotherapics; the need for long-term treatment; the importance of depression in the general health care system; and the clear relationship between depression and suicide. New opportunities have emerged for research in a more public-hcalth-oricntcd model, in prevention, and in dissemination.</p><p>Depression remains a central concern to older people, their families, and the clinicians who take care of them. Even when it appears to be an understandable response to illness, the onset of depression should be viewed as a sentinel event that increases the risk for subsequent declines in health status and functional ability. Early recognition, diagnosis, and initiation of treatment of depression in older persons present opportunities for improvements in quality of life, the prevention of suffering or premature death, and the maintenance of optimal levels of function and independence for older people.</p></sec></body><back><notes><p>Sections of this paper represents an expansion of material originally published in the <italic>Journal of the American Medical Association</italic> (Lebowitz et al, 1997) and in the <italic>Annual Review of Gerontology and Geriatrics</italic> (Lebowitz and Harris, in press).</p></notes><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebowitz</surname></name><name><surname>BD</surname></name><name><surname>Pearson</surname><given-names>JL.</given-names></name><name><surname>Cohen</surname><given-names>GD.</given-names></name></person-group><article-title>Older Americans and their illnesses. In: Salzman C, ed.</article-title><source><italic>Clinical Geriatric Psychopharmacology.</italic> 3rd edition. Baltimore, Md: Williams and Wilkins;</source><year>1998</year><fpage>3</fpage><lpage>20</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>CJL.</given-names></name><name><surname>Lopez</surname><given-names>AD.</given-names></name><name><surname>eds</surname></name></person-group><source><italic>The Global Burden of Disease.</italic> Cambridge, Mass: Harvard University Press;</source><year>1996</year></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duman</surname><given-names>RS.</given-names></name><name><surname>Heninger</surname><given-names>GR.</given-names></name><name><surname>Nestler</surname><given-names>EJ.</given-names></name></person-group><article-title>A molecular and cellular theory of depression.</article-title><source><italic>Arch Gen Psychiatry.</italic></source><year>1997</year><volume>54</volume><fpage>597</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">9236543</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Bilker</surname><given-names>W.</given-names></name><name><surname>Udupa</surname><given-names>J.</given-names></name><name><surname>Gottlieb</surname><given-names>G.</given-names></name></person-group><article-title>Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI.</article-title><source><italic>Proc Natl Acad Sci USA.</italic></source><year>1998</year><volume>95</volume><fpage>7654</fpage><lpage>7658</lpage><pub-id pub-id-type="pmid">9636205</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meltzer</surname><given-names>CC.</given-names></name><name><surname>Smith</surname><given-names>G.</given-names></name><name><surname>DeKosky</surname><given-names>ST.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging.</article-title><source><italic>Neuropsychopharmacology.</italic></source><year>1998</year><volume>18</volume><fpage>407</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">9571651</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musselman</surname><given-names>DL.</given-names></name><name><surname>Evans</surname><given-names>DL.</given-names></name><name><surname>Nemeroff</surname><given-names>CB.</given-names></name></person-group><article-title>The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment.</article-title><source><italic>Arch Gen Psychiatry.</italic></source><year>1998</year><volume>55</volume><fpage>580</fpage><lpage>592</lpage><pub-id pub-id-type="pmid">9672048</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheline</surname><given-names>Yl.</given-names></name><name><surname>Wang</surname><given-names>PW.</given-names></name><name><surname>Gado</surname><given-names>MH.</given-names></name><name><surname>Csernansky</surname><given-names>JG.</given-names></name><name><surname>Vannier</surname><given-names>MW.</given-names></name></person-group><article-title>Hippocampal atrophy in recurrent major depression.</article-title><source><italic>Proc Natl Acad Sci USA.</italic></source><year>1996</year><volume>93</volume><fpage>3908</fpage><lpage>3913</lpage><pub-id pub-id-type="pmid">8632988</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><article-title>Diagnosis and Treatment of Depression in Late Life.</article-title><source><italic>NIH Consens DevConf Consens Statement</italic></source><year>1991</year><volume>9(3)</volume><fpage>Nov 4</fpage><lpage>6</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>JJ.</given-names></name><name><surname>Anthony</surname><given-names>JC.</given-names></name><name><surname>Muthen</surname><given-names>BG.</given-names></name></person-group><article-title>Age differences in the symptoms of depression: a latent trait analysis.</article-title><source><italic>J Gerontol Psychol Sci.</italic></source><year>1994</year><volume>49</volume><fpage>P251</fpage><lpage>P264</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebowitz</surname><given-names>BD.</given-names></name><name><surname>Pearson</surname><given-names>JL.</given-names></name><name><surname>Schneider</surname><given-names>LS.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Diagnosis and treatment of depression in late life: consensus statement update.</article-title><source><italic>JAMA.</italic></source><year>1997</year><volume>278</volume><fpage>1186</fpage><lpage>1190</lpage><pub-id pub-id-type="pmid">9326481</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffey</surname><given-names>CE.</given-names></name><name><surname>Wilkinson</surname><given-names>WE.</given-names></name><name><surname>Weiner</surname><given-names>RD.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study.</article-title><source><italic>Arch Gen Psychiatry.</italic></source><year>1993</year><volume>50</volume><fpage>7</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">8422224</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ketter</surname><given-names>TA.</given-names></name><name><surname>George</surname><given-names>MS.</given-names></name><name><surname>Kimbrell</surname><given-names>TA.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Functional brain imaging, limbic function and affective disorders.</article-title><source><italic>Neuroscientist.</italic></source><year>1996</year><volume>2</volume><fpage>55</fpage><lpage>65</lpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drevets</surname><given-names>WC.</given-names></name><name><surname>Price</surname><given-names>JL.</given-names></name><name><surname>Simpson</surname><given-names>JR.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Subgenual prefrontal cortex abnormalities in mood disorders.</article-title><source><italic>Nature.</italic></source><year>1997</year><volume>386</volume><fpage>824</fpage><lpage>827</lpage><pub-id pub-id-type="pmid">9126739</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>SH.</given-names></name><name><surname>Javanmard</surname><given-names>M.</given-names></name><name><surname>Vaccarino</surname><given-names>FJ.</given-names></name></person-group><article-title>A review of functional neuroimaging in mood disorders: positron emission tomography and depression.</article-title><source><italic>Can J Psychiatry.</italic></source><year>1997</year><volume>42</volume><fpage>467</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">9220109</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Miller</surname><given-names>D.</given-names></name><name><surname>Ewbank</surname><given-names>D.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Quantitative anatomic measures and comorbid medical illness in late-life major depression.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1997</year><volume>5</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">9169241</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulos</surname><given-names>GS.</given-names></name><name><surname>Young</surname><given-names>RC.</given-names></name><name><surname>Shindeckler</surname><given-names>R.</given-names></name></person-group><article-title>Brain computed tomography in geriatric depression and primary degenerative dementia.</article-title><source><italic>Biol Psychiatry.</italic></source><year>1992</year><volume>31</volume><fpage>591</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">1581438</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>KRR.</given-names></name><name><surname>Gadde</surname><given-names>KM.</given-names></name></person-group><article-title>The pathophysiologic basis for late-life depression: imaging studies of the aging brain.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1996</year><volume>4(suppl 1)</volume><fpage>S22</fpage><lpage>S33</lpage></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassuck</surname><given-names>SS.</given-names></name><name><surname>Berkman</surname><given-names>LF.</given-names></name><name><surname>Wypij</surname><given-names>D.</given-names></name></person-group><article-title>Depressive symptomatology and incident cognitive decline in an elderly community sample.</article-title><source><italic>Arch Gen Psychiatry.</italic></source><year>1998</year><volume>55</volume><fpage>1073</fpage><lpage>1081</lpage><pub-id pub-id-type="pmid">9862549</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyers</surname><given-names>BS.</given-names></name><name><surname>Bruce</surname><given-names>ML.</given-names></name></person-group><article-title>The depression-dementia conundrum: integrating clinical and epidemiological perspectives.</article-title><source><italic>Arch Gen Psychiatry.</italic></source><year>1998</year><volume>55</volume><fpage>1082</fpage><lpage>1083</lpage><pub-id pub-id-type="pmid">9862550</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulos</surname><given-names>GS.</given-names></name><name><surname>Meyers</surname><given-names>BS.</given-names></name><name><surname>Young</surname><given-names>RC.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>The course of geriatric depression with &#x0201c;reversible dementia.&#x0201d;</article-title><source><italic>Am J Psychiatry.</italic></source><year>1993</year><volume>150</volume><fpage>1693</fpage><lpage>1699</lpage><pub-id pub-id-type="pmid">8105707</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulos</surname><given-names>GS.</given-names></name><name><surname>Meyers</surname><given-names>BS.</given-names></name><name><surname>Young</surname><given-names>RC.</given-names></name><name><surname>Campbell</surname><given-names>S.</given-names></name><name><surname>Silbersweig</surname><given-names>D.</given-names></name><name><surname>Charlson</surname><given-names>M.</given-names></name></person-group><article-title>&#x0201c;Vascular depression&#x0201d; hypothesis.</article-title><source><italic>Arch Gen Psychiatry.</italic></source><year>1997</year><volume>54</volume><fpage>915</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">9337771</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulos</surname><given-names>GS.</given-names></name><name><surname>Meyers</surname><given-names>BS.</given-names></name><name><surname>Young</surname><given-names>RC.</given-names></name><name><surname>Kakuma</surname><given-names>T.</given-names></name><name><surname>Silbersweig</surname><given-names>D.</given-names></name><name><surname>Charlson</surname><given-names>M.</given-names></name></person-group><article-title>Clinically defined vascular depression.</article-title><source><italic>Am J Psychiatry.</italic></source><year>1997</year><volume>154</volume><fpage>562</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">9090349</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leuchter</surname><given-names>AF.</given-names></name><name><surname>Dunkin</surname><given-names>JJ.</given-names></name><name><surname>Lufkin</surname><given-names>RB.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Effect of white matter disease on functional connections in the aging brain.</article-title><source><italic>J Neurol Neurosurg Psychiatry.</italic></source><year>1994</year><volume>57</volume><fpage>1347</fpage><lpage>1354</lpage><pub-id pub-id-type="pmid">7964810</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leuchter</surname><given-names>AF.</given-names></name><name><surname>Simon</surname><given-names>SL.</given-names></name><name><surname>Daly</surname><given-names>KA.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Quantitative EEG correlates of outcome in older psychiatric patients. Part II: Two-year follow-up of patients with depression.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1994</year><volume>2</volume><fpage>290</fpage><lpage>299</lpage></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>IR.</given-names></name></person-group><article-title>On the inseparability of medical and physical health in aged persons: lessons from depression and medical comorbidity.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1996</year><volume>4</volume><fpage>1</fpage><lpage>16</lpage></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whooley</surname><given-names>MA.</given-names></name><name><surname>Browner</surname><given-names>WS.</given-names></name></person-group><article-title>Association between depressive symptoms and mortality in older women: study of osteoporotic fractures research group.</article-title><source><italic>Arch intern Med.</italic></source><year>1998</year><volume>158</volume><fpage>2129</fpage><lpage>2135</lpage><pub-id pub-id-type="pmid">9801180</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>ML.</given-names></name><name><surname>Hoff</surname></name><name><surname>RA.</surname></name></person-group><article-title>Social and physical health risk factors for first onset major depressive disorder in a community sample.</article-title><source><italic>Soc Psychiatry Psychiatr Epidemiol.</italic></source><year>1994</year><volume>29</volume><fpage>165</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">7939965</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>ML.</given-names></name><name><surname>Seeman</surname><given-names>TE.</given-names></name><name><surname>Merrill</surname><given-names>SS.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>The impact of depressive symptomatology on physical disability: MacArthur studies of successful aging.</article-title><source><italic>Am J Pub Health.</italic></source><year>1994</year><volume>84</volume><fpage>1796</fpage><lpage>1799</lpage><pub-id pub-id-type="pmid">7977920</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>ML.</given-names></name></person-group><article-title>The association between depression and disability.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1999</year><volume>7</volume><fpage>8</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">9919315</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steffens</surname><given-names>DC.</given-names></name><name><surname>Hays</surname><given-names>JC.</given-names></name><name><surname>Krishnan</surname><given-names>RRK.</given-names></name></person-group><article-title>Disability in geriatric depression.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1999</year><volume>7</volume><fpage>34</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">9919318</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borson</surname><given-names>S.</given-names></name><name><surname>McDonald</surname><given-names>GJ.</given-names></name><name><surname>Gayle</surname><given-names>T.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease.</article-title><source><italic>Psychosomatics.</italic></source><year>1992</year><volume>33</volume><fpage>190</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">1557484</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>J.</given-names></name><name><surname>Weissman</surname><given-names>MM.</given-names></name><name><surname>Klerman</surname><given-names>GL.</given-names></name></person-group><article-title>Service utilization and social morbidity associated with depressive symptoms in the community.</article-title><source><italic>JAMA.</italic></source><year>1992</year><volume>267</volume><fpage>1478</fpage><lpage>1483</lpage><pub-id pub-id-type="pmid">1538538</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judd</surname><given-names>LL.</given-names></name><name><surname>Rapaport</surname><given-names>MH.</given-names></name><name><surname>Paulus</surname><given-names>MP.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Subsyndromal symptomatic depression: a new mood disorder.</article-title><source><italic>J Clin Psychiatry</italic></source><year>1994</year><volume>555</volume><fpage>18</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">8077164</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><article-title>American Psychiatric Association.</article-title><source><italic>Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, DSM-IV.<sup>TM</sup></italic> Washington, DC: American Psychiatric Press;</source><year>1994</year></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenig</surname><given-names>HG.</given-names></name><name><surname>Blazer</surname><given-names>DG.</given-names></name></person-group><article-title>Minor depression in late tife.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1996</year><volume>4(suppl 1)</volume><fpage>S14</fpage><lpage>S21</lpage></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossey</surname><given-names>JM.</given-names></name><name><surname>Knott</surname><given-names>KA.</given-names></name><name><surname>Craik</surname><given-names>R.</given-names></name></person-group><article-title>The effects of persistent depressive symptoms on hip fracture recovery.</article-title><source><italic>J Gerontol Med Sci.</italic></source><year>1990</year><volume>45</volume><fpage>M163</fpage><lpage>M168</lpage></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossey</surname><given-names>JM.</given-names></name><name><surname>Knott</surname><given-names>KA.</given-names></name><name><surname>Higgins</surname><given-names>M.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Effectiveness of a psychosocial intervention. Interpersonal Counseling, for subdysthymic depression in medically ill elderly.</article-title><source><italic>J Gerontol Med Sci.</italic></source><year>1996</year><volume>51A</volume><fpage>M172</fpage><lpage>M178</lpage></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>A.</given-names></name><name><surname>Pearlstein</surname><given-names>T.</given-names></name></person-group><article-title>Evaluation and treatment of changes in mood, sleep, and sexual functioning associated with menopause.</article-title><source><italic>Obstet Gynecol Clin North Am.</italic></source><year>1994</year><volume>21</volume><fpage>391</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">7936551</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>P.</given-names></name><name><surname>Rubinow</surname><given-names>D.</given-names></name></person-group><article-title>Neuroregulatory role of gonadal steroids in human.</article-title><source><italic>Psychopharmacol Bull.</italic></source><year>1997</year><volume>33</volume><fpage>219</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">9230633</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidman</surname><given-names>SN.</given-names></name><name><surname>Walsh</surname><given-names>BT.</given-names></name></person-group><article-title>Testosterone and depression in aging men.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1999</year><volume>7</volume><fpage>18</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">9919317</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truss</surname><given-names>M.</given-names></name><name><surname>Beato</surname><given-names>M.</given-names></name></person-group><article-title>Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors.</article-title><source><italic>Endocr Rev.</italic></source><year>1993</year><volume>14</volume><fpage>459</fpage><lpage>479</lpage><pub-id pub-id-type="pmid">8223341</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>LS.</given-names></name></person-group><article-title>Pharmacological considerations in the treatment of late life depression.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1996</year><volume>4(suppl 1)</volume><fpage>S51</fpage><lpage>S65</lpage></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzman</surname><given-names>C.</given-names></name><name><surname>Schneider</surname><given-names>L.</given-names></name><name><surname>Alexopoulos</surname><given-names>G.</given-names></name></person-group><article-title>Pharmacological treatment of depression in late life. In: Bloom F, Kupfer D, eds.</article-title><source><italic>Psychopharmacology: Fourth Generation of Progress. New York, NY: Raven Press;</italic></source><year>1995</year><fpage>1471</fpage><lpage>1477</lpage></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laghrissi-Thode</surname><given-names>F.</given-names></name><name><surname>Pollock</surname><given-names>BG.</given-names></name><name><surname>Miller</surname><given-names>MC.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients.</article-title><source><italic>Psychopharm Bull.</italic></source><year>1995</year><volume>31</volume><fpage>659</fpage><lpage>663</lpage></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemeroff</surname><given-names>CB.</given-names></name><name><surname>DeVane</surname><given-names>CL.</given-names></name><name><surname>Pollock</surname><given-names>BG.</given-names></name></person-group><article-title>Newer antidepressants and the cytochrome P450 system.</article-title><source><italic>Am J Psychiatry.</italic></source><year>1996</year><volume>153</volume><fpage>311</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">8610817</pub-id></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Von Moltke</surname><given-names>LL.</given-names></name><name><surname>Abernethy</surname><given-names>DR.</given-names></name><name><surname>Greenblatt</surname><given-names>DJ.</given-names></name></person-group><article-title>Kinetics and dynamics of psychotropic drugs in the elderly. In: Salzman C, ed.</article-title><source><italic>Clinical Geriatric Psychopharmacology.</italic> 3rd edition. Baltimore, Md: Williams and Wilkins;</source><year>1998</year><fpage>70</fpage><lpage>93</lpage></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>CF.</given-names></name><name><surname>Frank</surname><given-names>E.</given-names></name><name><surname>Perel</surname><given-names>JM.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.</article-title><source><italic>JAMA.</italic></source><year>1999</year><volume>281</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">9892449</pub-id></element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niederehe</surname><given-names>G.</given-names></name></person-group><article-title>Psychosocial treatments with depressed older adults: a research update.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1996(suppl 1)</year><volume>4</volume><fpage>S66</fpage><lpage>S78</lpage></element-citation></ref><ref id="ref49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niederehe</surname><given-names>G.</given-names></name><name><surname>Schneider</surname><given-names>LS.</given-names></name></person-group><article-title>Treatments for anxiety and depression in the aged. In: Nathan PE, Gorman JM, eds.</article-title><source><italic>A Guide to Treatments that Work.</italic> New York, NY: Oxford University Press;</source><year>1998</year><fpage>270</fpage><lpage>287</lpage></element-citation></ref><ref id="ref50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arean</surname><given-names>PA.</given-names></name><name><surname>Perri</surname><given-names>MG.</given-names></name><name><surname>Nezu</surname><given-names>AM.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Comparative effectiveness of social problem-solving therapy and reminiscence therapy as treatments for depression in older adults.</article-title><source><italic>J Consult Clin Psychol.</italic></source><year>1993</year><volume>61</volume><fpage>1003</fpage><lpage>1010</lpage><pub-id pub-id-type="pmid">8113478</pub-id></element-citation></ref><ref id="ref51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prudic</surname><given-names>J.</given-names></name><name><surname>Haskett</surname><given-names>RF.</given-names></name><name><surname>Mulsant</surname><given-names>B.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Resistance to antidepressant medications and short-term clinical response to ECT.</article-title><source><italic>Am J Psychiatry.</italic></source><year>1996</year><volume>153</volume><fpage>985</fpage><lpage>992</lpage><pub-id pub-id-type="pmid">8678194</pub-id></element-citation></ref><ref id="ref52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sackeim</surname><given-names>HA.</given-names></name></person-group><article-title>The use of electroconvulsive therapy in late-life depression. In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff AJ, eds.</article-title><source><italic>Diagnosis and Treatment of Depression in Late Life.</italic> Washington DC: American Psychiatric Press;</source><year>1994</year><fpage>259</fpage><lpage>278</lpage></element-citation></ref><ref id="ref53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sackeim</surname><given-names>HA.</given-names></name></person-group><article-title>Continuation therapy following ECT: directions for further research.</article-title><source><italic>Psychopharm Bull.</italic></source><year>1994</year><volume>30</volume><fpage>501</fpage><lpage>521</lpage></element-citation></ref><ref id="ref54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulos</surname><given-names>GS.</given-names></name><name><surname>Meyers</surname><given-names>BS.</given-names></name><name><surname>Young</surname><given-names>RC.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Recovery in geriatric depression.</article-title><source><italic>Arch Gen Psychiatry.</italic></source><year>1996</year><volume>53</volume><fpage>305</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">8634008</pub-id></element-citation></ref><ref id="ref55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>CF.</given-names></name><name><surname>Frank</surname><given-names>E.</given-names></name><name><surname>Kupfer</surname><given-names>DJ.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Treatment outcomes in recurrent major depression: a post hoc comparison of elderly (&#x0201c;young old&#x0201d;) and midlife patients.</article-title><source><italic>Ami J Psychiatry.</italic></source><year>1996</year><volume>53</volume><fpage>1288</fpage><lpage>1292</lpage></element-citation></ref><ref id="ref56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>CF.</given-names></name><name><surname>Frank</surname><given-names>E.</given-names></name><name><surname>Dew</surname><given-names>MA.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Treatment of 70+ year-olds with recurrent major depression: excellent short-term but brittle long-term results.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1999</year><volume>7</volume><fpage>64</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">9919322</pub-id></element-citation></ref><ref id="ref57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fries</surname><given-names>BE.</given-names></name><name><surname>Mehr</surname><given-names>DR.</given-names></name><name><surname>Schneider</surname><given-names>D.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Mental dysfunction and resource use in nursing homes.</article-title><source><italic>Medical Care.</italic></source><year>1993</year><volume>31</volume><fpage>898</fpage><lpage>920</lpage><pub-id pub-id-type="pmid">8412392</pub-id></element-citation></ref><ref id="ref58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>GE.</given-names></name><name><surname>Von Korff</surname><given-names>M.</given-names></name><name><surname>Barlow</surname><given-names>W.</given-names></name></person-group><article-title>Health care costs of primary care patients with recognized depression.</article-title><source><italic>Arch Gen Psychiatry</italic></source><year>1995</year><volume>52</volume><fpage>850</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">7575105</pub-id></element-citation></ref><ref id="ref59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henk</surname><given-names>HJ.</given-names></name><name><surname>Katzelnick</surname><given-names>DJ.</given-names></name><name><surname>Kobak</surname><given-names>KA.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization.</article-title><source><italic>Arch Gen Psychiatry.</italic></source><year>1996</year><volume>53</volume><fpage>899</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">8857866</pub-id></element-citation></ref><ref id="ref60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Von Korff</surname><given-names>M.</given-names></name><name><surname>Ormel</surname><given-names>H.</given-names></name><name><surname>Katon</surname><given-names>W.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Disability and depression among high utilizers of health care.</article-title><source><italic>Arch Gen Psychiatry.</italic></source><year>1992</year><volume>19</volume><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">1550468</pub-id></element-citation></ref><ref id="ref61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper-Patrick</surname><given-names>L.</given-names></name><name><surname>Crum</surname><given-names>RM.</given-names></name><name><surname>Ford</surname><given-names>DE.</given-names></name></person-group><article-title>Characteristics of patients with major depression who received care in general medical and specialty health settings.</article-title><source><italic>Medical Care.</italic></source><year>1994</year><volume>32</volume><fpage>15</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">8277799</pub-id></element-citation></ref><ref id="ref62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callahan</surname><given-names>CM.</given-names></name><name><surname>Hui</surname><given-names>SL.</given-names></name><name><surname>Nienaber</surname><given-names>NA.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Longitudinal study of depression and health services use among elderly primary care patients. J Am</article-title><source><italic>Geriatr Soc.</italic></source><year>1994</year><volume>42</volume><fpage>833</fpage><lpage>838</lpage></element-citation></ref><ref id="ref63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams-Russo</surname><given-names>P.</given-names></name></person-group><article-title>Barriers to diagnosis and treatment of depression in primary care settings.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1996</year><volume>4(suppl 1)</volume><fpage>S84</fpage><lpage>S90</lpage></element-citation></ref><ref id="ref64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams-Russo</surname><given-names>P.</given-names></name><name><surname>Petersen</surname><given-names>J.</given-names></name><name><surname>Charlson</surname><given-names>ME.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Longitudinal course of depressive symptoms after bypass surgery. Presented at NIMH Primary Care Conference, Rockville, Md; July</article-title><year>1996</year></element-citation></ref><ref id="ref65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callahan</surname><given-names>CM.</given-names></name><name><surname>Wolinsky</surname><given-names>FD.</given-names></name></person-group><article-title>Hospitalization for major depression among older Americans.</article-title><source><italic>J Gerontol Med Sci.</italic></source><year>1995</year><volume>50A</volume><fpage>M196</fpage><lpage>M202</lpage></element-citation></ref><ref id="ref66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenig</surname><given-names>HG.</given-names></name><name><surname>Kuchibhatla</surname><given-names>M.</given-names></name></person-group><article-title>Use of health services by medically ill depressed elderly patients after hospital discharge.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1999</year><volume>7</volume><fpage>48</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">9919320</pub-id></element-citation></ref><ref id="ref67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olfson</surname><given-names>M.</given-names></name><name><surname>Pincus</surname><given-names>HA.</given-names></name></person-group><article-title>Outpatient mental health care in nonhospital settings: distribution of patients across provider groups.</article-title><source><italic>Am J Psychiatry</italic></source><year>1996</year><volume>153</volume><fpage>1353</fpage><lpage>1356</lpage><pub-id pub-id-type="pmid">8831450</pub-id></element-citation></ref><ref id="ref68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callahan</surname><given-names>CM.</given-names></name><name><surname>Hendrie</surname><given-names>HC.</given-names></name><name><surname>Dittus</surname><given-names>RS.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Improving treatment of late life depression in primary care: a randomized clinical trial.</article-title><source><italic>J Am Geriatr Soc.</italic></source><year>1994</year><volume>42</volume><fpage>839</fpage><lpage>846</lpage><pub-id pub-id-type="pmid">8046193</pub-id></element-citation></ref><ref id="ref69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klinkman</surname><given-names>MS.</given-names></name><name><surname>Okkes</surname><given-names>I.</given-names></name></person-group><article-title>Mental health problems in primary care: a research agenda.</article-title><source><italic>J Fam Pract.</italic></source><year>1998</year><volume>47</volume><fpage>379</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">9834775</pub-id></element-citation></ref><ref id="ref70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebowitz</surname><given-names>BD.</given-names></name></person-group><article-title>Priorities for agenda building: mental health and primary care.</article-title><source><italic>J Fam Pract.</italic></source><year>1998</year><volume>47</volume><fpage>341</fpage><pub-id pub-id-type="pmid">9834767</pub-id></element-citation></ref><ref id="ref71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henriksson</surname><given-names>MM.</given-names></name><name><surname>Marttunen</surname><given-names>MJ.</given-names></name><name><surname>Isometsa</surname><given-names>ET.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Mental disorders in elderly suicide.</article-title><source><italic>Int Psychogeriatr.</italic></source><year>1995</year><volume>7</volume><fpage>275</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">8829433</pub-id></element-citation></ref><ref id="ref72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conwell</surname><given-names>Y.</given-names></name><name><surname>Duberstein</surname><given-names>PR.</given-names></name><name><surname>Cox</surname><given-names>C.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study.</article-title><source><italic>Am J Psychiatry.</italic></source><year>1996</year><volume>153</volume><fpage>1001</fpage><lpage>1008</lpage><pub-id pub-id-type="pmid">8678167</pub-id></element-citation></ref><ref id="ref73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conwell</surname><given-names>Y.</given-names></name></person-group><article-title>Management of suicidal behavior in the elderly.</article-title><source><italic>Psychiatr Clin North Am.</italic></source><year>1997</year><volume>20</volume><fpage>667</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">9323319</pub-id></element-citation></ref><ref id="ref74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebowitz</surname><given-names>BD.</given-names></name><name><surname>Harris</surname><given-names>HW.</given-names></name></person-group><article-title>Treatment research in geriatric psychiatry: from regulatory to public health considerations.</article-title><source><italic>Am J Geriatr Psychiatry.</italic></source><year>1998</year><volume>6</volume><fpage>101</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">9581205</pub-id></element-citation></ref><ref id="ref75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leber</surname><given-names>PD.</given-names></name><name><surname>Davis</surname><given-names>CS.</given-names></name></person-group><article-title>Threats to the validity of clinical trials employing enrichment strategies for sample selection.</article-title><source><italic>Control Clin Trials.</italic></source><year>1998</year><volume>19</volume><fpage>178</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">9551282</pub-id></element-citation></ref><ref id="ref76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzman</surname><given-names>C.</given-names></name><name><surname>Schneider</surname><given-names>LS.</given-names></name><name><surname>Lebowitz</surname><given-names>BD.</given-names></name></person-group><article-title>Antidepressant treatment of very old patients.</article-title><source><italic>Am J Geriatr Psychiatry</italic></source><year>1993</year><volume>1</volume><fpage>21</fpage><lpage>29</lpage></element-citation></ref><ref id="ref77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horowitz</surname><given-names>MJ.</given-names></name><name><surname>Siegel</surname><given-names>B.</given-names></name><name><surname>Holen</surname><given-names>A.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Diagnostic criteria for complicated grief disorder.</article-title><source><italic>Am J Psychiatry.</italic></source><year>1997</year><volume>154</volume><fpage>904</fpage><lpage>910</lpage><pub-id pub-id-type="pmid">9210739</pub-id></element-citation></ref><ref id="ref78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prigerson</surname><given-names>HG.</given-names></name><name><surname>Frank</surname><given-names>E.</given-names></name><name><surname>Kasl</surname><given-names>SV.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Complicated grief and bereavement-related depression as distinct disorders: preliminary empirical validation in elderly bereaved spouses.</article-title><source><italic>Am J Psychiatry.</italic></source><year>1995</year><volume>152</volume><fpage>22</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">7802116</pub-id></element-citation></ref><ref id="ref79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prigerson</surname><given-names>HG.</given-names></name><name><surname>Bierhals</surname><given-names>AJ.</given-names></name><name><surname>Kasl</surname><given-names>SV.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Traumatic grief as a risk factor for mental and physical morbidity.</article-title><source><italic>Am J Psychiatry.</italic></source><year>1997</year><volume>154</volume><fpage>616</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">9137115</pub-id></element-citation></ref><ref id="ref80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astin</surname><given-names>JA.</given-names></name></person-group><article-title>Why patients use alternative medicine: results of a national study.</article-title><source><italic>JAMA</italic></source><year>1998</year><volume>279</volume><fpage>1548</fpage><lpage>1553</lpage><pub-id pub-id-type="pmid">9605899</pub-id></element-citation></ref><ref id="ref81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>DM.</given-names></name><name><surname>Davis</surname><given-names>RB.</given-names></name><name><surname>Ettner</surname><given-names>SL.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.</article-title><source><italic>JAMA.</italic></source><year>1998</year><volume>280</volume><fpage>1569</fpage><lpage>1575</lpage><pub-id pub-id-type="pmid">9820257</pub-id></element-citation></ref><ref id="ref82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emmanuel</surname><given-names>NP.</given-names></name><name><surname>Cosby</surname><given-names>C.</given-names></name><name><surname>Crawford</surname><given-names>M.</given-names></name><name><surname>et al.</surname></name></person-group><article-title>Prevalence of herbal products use by subjects evaluated for pharmacological clinical trials. Poster Presentation, 38th annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, Boca Raton, Fl;</article-title><year>1998</year></element-citation></ref><ref id="ref83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehman</surname><given-names>AF.</given-names></name><name><surname>Steinwachs</surname><given-names>DM.</given-names></name></person-group><article-title>Patterns of usual care for schizophrenia: initial results from the schizophrenia patient outcomes research team (PORT) client survey.</article-title><source><italic>Schizophr Bull.</italic></source><year>1998</year><volume>24</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">9502543</pub-id></element-citation></ref><ref id="ref84"><label>84</label><element-citation publication-type="journal"><article-title>Geriatric Psychiatry Alliance.</article-title><source><italic>Depression in Late Life: Not a Natural Part of Aging.</italic> Bethesda, Md: American Association for Geriatric Psychiatry;</source><year>1997</year></element-citation></ref></ref-list></back></article>